The DOI matches its Crossref record; 82 of the 82 references it cites were found in a registry or an index.
Little Peptide, Big Effects: The Role of LL-37 in Inflammation and Autoimmune Disease
Open accessAbstract
The innate immune system utilizes many approaches for defense against invading microorganisms, including complement-mediated lysis, engulfment, formation of neutrophil extracellular traps, and release of antimicrobial peptides. Although classically thought to be driven by adaptive immunity, the development of autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus is increasingly associated with dysregulated innate immune pathways. An emerging theme within this literature is the contribution of antimicrobial peptides to the development of autoimmune disorders. This is best exemplified in atopic dermatitis and psoriasis where the defensins and the single human cathelicidin, LL-37, may contribute to disease. Furthermore, in the past few years, a role for LL-37 has emerged in the pathogenesis of systemic lupus erythematosus, rheumatoid arthritis, atherosclerosis, and possibly other diseases. In this review, we discuss the role of LL-37 and its murine ortholog, mCRAMP, in the modulation of immune and inflammatory pathways and their effects on autoimmune and inflammatory diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Girnita, A., Zheng, H., Grönberg, A., Girnita, L., & Ståhle, M. (2011) · Oncogene · doi:10.1038/onc.2011.239 · Cited by 90
RetractedInflammation, Atherosclerosis, and Coronary Artery Disease
Hansson, G. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043430 · Cited by 8,773
Endogenous Antimicrobial Peptides and Skin Infections in Atopic Dermatitis
Ong, P. Y., Ohtake, T., Brandt, C., Strickland, I., Boguniewicz, M., Ganz, T., Gallo, R. L., & Leung, D. Y. M. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021481 · Cited by 1,960
Plasmacytoid dendritic cells sense self-DNA coupled with antimicrobial peptide
Lande, R., Gregorio, J., Facchinetti, V., Chatterjee, B., Wang, Y.-H., Homey, B., Cao, W., Wang, Y.-H., Su, B., Nestle, F. O., et al. (2007) · Nature · doi:10.1038/nature06116 · Cited by 1,910
Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis
Hakkim, A., Fürnrohr, B. G., Amann, K., Laube, B., Abed, U. A., Brinkmann, V., Herrmann, M., Voll, R. E., & Zychlinsky, A. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909927107 · Cited by 1,469
Garcia-Romo, G. S., Caielli, S., Vega, B., Connolly, J., Allantaz, F., Xu, Z., Punaro, M., Baisch, J., Guiducci, C., Coffman, R. L., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001201 · Cited by 1,383
Khandpur, R., Carmona-Rivera, C., Vivekanandan-Giri, A., Gizinski, A., Yalavarthi, S., Knight, J. S., Friday, S., Li, S., Patel, R. M., Subramanian, V., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3005580 · Cited by 1,337
Self-citationLande, R., Ganguly, D., Facchinetti, V., Frasca, L., Conrad, C., Gregorio, J., Meller, S., Chamilos, G., Sebasigari, R., Riccieri, V., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001180 · Cited by 1,303
Villanueva, E., Yalavarthi, S., Berthier, C. C., Hodgin, J. B., Khandpur, R., Lin, A. M., Rubin, C. J., Zhao, W., Olsen, S. H., Klinker, M., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1100450 · Cited by 1,241
Self-citationInnate antimicrobial peptide protects the skin from invasive bacterial infection
Nizet, V., Ohtake, T., Lauth, X., Trowbridge, J., Rudisill, J., Dorschner, R. A., Pestonjamasp, V., Piraino, J., Huttner, K., & Gallo, R. L. (2001) · Nature · doi:10.1038/35106587 · Cited by 1,198
Type I Interferons in Host Defense
Stetson, D. B., & Medzhitov, R. (2006) · Immunity · doi:10.1016/j.immuni.2006.08.007 · Cited by 1,195
Sørensen, O. E., Follin, P., Johnsen, A. H., Calafat, J., Tjabringa, G. S., Hiemstra, P. S., & Borregaard, N. (2001) · Blood · doi:10.1182/blood.v97.12.3951 · Cited by 894
Targeting Toll-like receptors: emerging therapeutics?
Hennessy, E. J., Parker, A. E., & O'Neill, L. A. J. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3203 · Cited by 886
An angiogenic role for the human peptide antibiotic LL-37/hCAP-18
Koczulla, R., von Degenfeld, G., Kupatt, C., Krötz, F., Zahler, S., Gloe, T., Issbrücker, K., Unterberger, P., Zaiou, M., Lebherz, C., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci17545 · Cited by 863
APD: the Antimicrobial Peptide Database
Wang, Z. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh025 · Cited by 808
Activities of LL-37, a Cathelin-Associated Antimicrobial Peptide of Human Neutrophils
Turner, J., Cho, Y., Dinh, N.-N., Waring, A. J., & Lehrer, R. I. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.9.2206 · Cited by 798
Liu, P. T., Stenger, S., Tang, D. H., & Modlin, R. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.4.2060 · Cited by 773
Self-RNA–antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8
Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., Homey, B., Barrat, F. J., Zal, T., & Gilliet, M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090480 · Cited by 740
The Human Antimicrobial Peptide LL-37 Is a Multifunctional Modulator of Innate Immune Responses
Scott, M. G., Davidson, D. J., Gold, M. R., Bowdish, D., & Hancock, R. E. W. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.7.3883 · Cited by 713
Denny, M. F., Yalavarthi, S., Zhao, W., Thacker, S. G., Anderson, M., Sandy, A. R., McCune, W. J., & Kaplan, M. J. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0902199 · Cited by 701
Self-citationChromek, M., Slamová, Z., Bergman, P., Kovács, L., Podracká, L., Ehrén, I., Hökfelt, T., Gudmundsson, G. H., Gallo, R. L., Agerberth, B., et al. (2006) · Nature Medicine · doi:10.1038/nm1407 · Cited by 652
Oren, Z., Lerman, J. C., Gudmundsson, G. H., Agerberth, B., & Shai, Y. (1999) · Biochemical Journal · doi:10.1042/0264-6021:3410501 · Cited by 599
Human CAP18: a novel antimicrobial lipopolysaccharide-binding protein
Larrick, J. W., Hirata, M., Balint, R. F., Lee, J., Zhong, J., & Wright, S. C. (1995) · Infection and Immunity · doi:10.1128/iai.63.4.1291-1297.1995 · Cited by 573
A comprehensive summary of LL-37, the factotum human cathelicidin peptide
Vandamme, D., Landuyt, B., Luyten, W., & Schoofs, L. (2012) · Cellular Immunology · doi:10.1016/j.cellimm.2012.11.009 · Cited by 567
Makrygiannakis, D., Hermansson, M., Ulfgren, A.-K., Nicholas, A. P., Zendman, A. J. W., Eklund, A., Grunewald, J., Skold, C. M., Klareskog, L., & Catrina, A. I. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.075192 · Cited by 550
Kahlenberg, J. M., Carmona-Rivera, C., Smith, C. K., & Kaplan, M. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202388 · Cited by 508
Self-citationKallikrein‐mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin
Yamasaki, K., Schauber, J., Coda, A., Lin, H., Dorschner, R. A., Schechter, N. M., Bonnart, C., Descargues, P., Hovnanian, A., & Gallo, R. L. (2006) · The FASEB Journal · doi:10.1096/fj.06-6075com · Cited by 462
Döring, Y., Manthey, H. D., Drechsler, M., Lievens, D., Megens, R. T. A., Soehnlein, O., Busch, M., Manca, M., Koenen, R. R., Pelisek, J., et al. (2012) · Circulation · doi:10.1161/circulationaha.111.046755 · Cited by 456
Cytosolic DNA Triggers Inflammasome Activation in Keratinocytes in Psoriatic Lesions
Dombrowski, Y., Peric, M., Koglin, S., Kammerbauer, C., Göß, C., Anz, D., Simanski, M., Gläser, R., Harder, J., Hornung, V., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002001 · Cited by 431
Elssner, A., Duncan, M., Gavrilin, M., & Wewers, M. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.8.4987 · Cited by 425
Endotoxin (Lipopolysaccharide) Neutralization by Innate Immunity Host-Defense Peptides
Rosenfeld, Y., Papo, N., & Shai, Y. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m504327200 · Cited by 370
Tokumaru, S., Sayama, K., Shirakata, Y., Komatsuzawa, H., Ouhara, K., Hanakawa, Y., Yahata, Y., Dai, X., Tohyama, M., Nagai, H., et al. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4662 · Cited by 358
Barlow, P. G., Svoboda, P., Mackellar, A., Nash, A. A., York, I. A., Pohl, J., Davidson, D. J., & Donis, R. O. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025333 · Cited by 357
The interferon signature in autoimmune diseases
Rönnblom, L., & Eloranta, M.-L. (2013) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835c7e32 · Cited by 294
Periodontal Disease and Rheumatoid Arthritis: A Systematic Review
Kaur, S., White, S., & Bartold, P. M. (2013) · Journal of Dental Research · doi:10.1177/0022034513483142 · Cited by 275
Tjabringa, G. S., Ninaber, D. K., Drijfhout, J. W., Rabe, K. F., & Hiemstra, P. S. (2006) · International Archives of Allergy and Immunology · doi:10.1159/000092305 · Cited by 246
Niessner, A., Sato, K., Chaikof, E. L., Colmegna, I., Goronzy, J. J., & Weyand, C. M. (2006) · Circulation · doi:10.1161/circulationaha.106.642801 · Cited by 243
Cathelicidin LL-37: An Antimicrobial Peptide with a Role in Inflammatory Skin Disease
Reinholz, M., Ruzicka, T., & Schauber, J. (2012) · Annals of Dermatology · doi:10.5021/ad.2012.24.2.126 · Cited by 236
Iimura, M., Gallo, R. L., Hase, K., Miyamoto, Y., Eckmann, L., & Kagnoff, M. F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4901 · Cited by 236
Pratesi, F., Dioni, I., Tommasi, C., Alcaro, M. C., Paolini, I., Barbetti, F., Boscaro, F., Panza, F., Puxeddu, I., Rovero, P., et al. (2014) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202765 · Cited by 235
Lack of Neutrophil-Derived CRAMP Reduces Atherosclerosis in Mice
Döring, Y., Drechsler, M., Wantha, S., Kemmerich, K., Lievens, D., Vijayan, S., Gallo, R. L., Weber, C., & Soehnlein, O. (2012) · Circulation Research · doi:10.1161/circresaha.112.265868 · Cited by 230
Yu, J., Mookherjee, N., Wee, K., Bowdish, D. M. E., Pistolic, J., Li, Y., Rehaume, L., & Hancock, R. E. W. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7684 · Cited by 212
The effect of smoking on clinical, laboratory, and radiographic status in rheumatoid arthritis.
Wolfe, F. (2000) · PubMed · Cited by 204
Transmembrane Pores Formed by Human Antimicrobial Peptide LL-37
Lee, C.-C., Sun, Y., Qian, S., & Huang, H. W. (2011) · Biophysical Journal · doi:10.1016/j.bpj.2011.02.018 · Cited by 202
LL-37 Directs Macrophage Differentiation toward Macrophages with a Proinflammatory Signature
van der Does, A. M., Beekhuizen, H., Ravensbergen, B., Vos, T., Ottenhoff, T. H. M., van Dissel, J. T., Drijfhout, J. W., Hiemstra, P. S., & Nibbering, P. H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1000376 · Cited by 193
Chamilos, G., Gregorio, J., Meller, S., Lande, R., Kontoyiannis, D. P., Modlin, R. L., & Gilliet, M. (2012) · Blood · doi:10.1182/blood-2012-01-401364 · Cited by 182
Kahlenberg, J. M., Thacker, S. G., Berthier, C. C., Cohen, C. D., Kretzler, M., & Kaplan, M. J. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101284 · Cited by 179
Self-citationBarlow, P. G., Li, Y., Wilkinson, T. S., Bowdish, D. M. E., Lau, Y. E., Cosseau, C., Haslett, C., Simpson, A. J., Hancock, R. E. W., & Davidson, D. J. (2006) · Journal of Leukocyte Biology · doi:10.1189/jlb.1005560 · Cited by 167
Host Defense Peptide LL-37 Selectively Reduces Proinflammatory Macrophage Responses
Brown, K. L., Poon, G. F. T., Birkenhead, D., Pena, O. M., Falsafi, R., Dahlgren, C., Karlsson, A., Bylund, J., Hancock, R. E. W., & Johnson, P. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1002508 · Cited by 163
Nardo, A. D., Braff, M. H., Taylor, K. R., Na, C., Granstein, R. D., McInturff, J. E., Krutzik, S. R., Modlin, R. L., & Gallo, R. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.3.1829 · Cited by 159
Park, K., Elias, P. M., Oda, Y., Mackenzie, D. S., Mauro, T. M., Holleran, W. M., & Uchida, Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.250431 · Cited by 151
Involvement of the Antimicrobial Peptide LL-37 in Human Atherosclerosis
Edfeldt, K., Agerberth, B., Rottenberg, M. E., Gudmundsson, G. H., Wang, X.-B., Mandal, K., Xu, Q., & Yan, Z. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000223901.08459.57 · Cited by 148
Caspase-1 Deficiency Decreases Atherosclerosis in Apolipoprotein E-Null Mice
Gage, J., Hasu, M., Thabet, M., & Whitman, S. C. (2012) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2011.10.013 · Cited by 141
Antimicrobial peptides are expressed and produced in healthy and inflamed human synovial membranes
Paulsen, F. P., Pufe, T., Conradi, L., Varoga, D. J., Tsokos, M., Papendieck, J., & Petersen, W. J. (2002) · The Journal of Pathology · doi:10.1002/path.1224 · Cited by 134
Therapeutic antimicrobial peptides may compromise natural immunity
Habets, M. G. J. L., & Brockhurst, M. A. (2012) · Biology Letters · doi:10.1098/rsbl.2011.1203 · Cited by 127
Molecular Basis of DNA Recognition in the Immune System
Atianand, M., & Fitzgerald, K. A. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203162 · Cited by 125
The vitamin D pathway: a new target for control of the skin’s immune response?
Schauber, J., & Gallo, R. L. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00768.x · Cited by 122
LL37 and Cationic Peptides Enhance TLR3 Signaling by Viral Double-stranded RNAs
Lai, Y. Y., Adhikarakunnathu, S., Bhardwaj, K., Ranjith-Kumar, C. T., Wen, Y., Jordan, J. L., Wu, L. H., Dragnea, B. G., Mateo, L. S., & Kao, C. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026632 · Cited by 122
Zhang, X., Oglęcka, K., Sandgren, S., Belting, M., Esbjörner, E. K., Nordén, B., & Gräslund, A. (2009) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2009.12.011 · Cited by 117
Neutrophil-Derived Cathelicidin Protects from Neointimal Hyperplasia
Soehnlein, O., Wantha, S., Simsekyilmaz, S., Döring, Y., Megens, R. T. A., Mause, S. F., Drechsler, M. D., Smeets, R., Weinandy, S., Schreiber, F., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002531 · Cited by 113
Türkoğlu, O., Emingil, G., Kütükçüler, N., & Atilla, G. (2009) · Journal of Periodontology · doi:10.1902/jop.2009.080532 · Cited by 113
Clinical Use of Colistin Induces Cross-Resistance to Host Antimicrobials in Acinetobacter baumannii
Napier, B. A., Burd, E. M., Satola, S. W., Cagle, S., Ray, S. M., McGann, P., Pohl, J., Lesho, E. P., & Weiss, D. S. (2013) · mBio · doi:10.1128/mbio.00021-13 · Cited by 108
Kilsgård, O., Andersson, P., Malmsten, M., Nordin, S. L., Linge, H. M., Eliasson, M., Sörenson, E., Erjefalt, J. S., Bylund, J., Olin, A. I., et al. (2011) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2010-0500oc · Cited by 107
Hing, T. C., Ho, S., Shih, D. Q., Ichikawa, R., Cheng, M., Chen, J., Chen, X., Law, I. K. M., Najarían, R. M., Kelly, C. P., et al. (2012) · Gut · doi:10.1136/gutjnl-2012-302180 · Cited by 101
Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrity
Otte, J., Zdebik, A., Brand, S., Chromik, A. M., Strauß, S., Schmitz, F., Steinstraesser, L., & Schmidt, W. E. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.03.009 · Cited by 99
Chen, X., Takai, T., Xie, Y., Niyonsaba, F., Okumura, K., & Ogawa, H. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.03.024 · Cited by 96
The Human Antimicrobial Peptide LL-37 Suppresses Apoptosis in Keratinocytes
Chamorro, C. I., Weber, G., Grönberg, A., Pivarcsi, A., & Ståhle, M. (2008) · Journal of Investigative Dermatology · doi:10.1038/jid.2008.321 · Cited by 94
Bone Loss in Rheumatoid Arthritis: Systemic, Periarticular, and Focal
Deal, C. L. (2012) · Current Rheumatology Reports · doi:10.1007/s11926-012-0253-7 · Cited by 94
IL‐18 Activity in Systemic Lupus Erythematosus
Favilli, F., Anzilotti, C., Martinelli, L., Quattroni, P., Martino, S. D., Pratesi, F., Neumann, D., Beermann, S., Novick, D., Dinarello, C. A., et al. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04742.x · Cited by 87
Complement, interferon and lupus
Elkon, K. B., & Santer, D. M. (2012) · Current Opinion in Immunology · doi:10.1016/j.coi.2012.08.004 · Cited by 85
Ciornei, C. D., Tapper, H., Bjartell, A. S., Sternby, N. H., & Bodelsson, M. (2006) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-6-49 · Cited by 78
Hoffmann, M. H., Bruns, H., Bäckdahl, L., Neregård, P., Niederreiter, B., i, M. H., Catrina, A. I., Agerberth, B., & Holmdahl, R. (2012) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2012-202218 · Cited by 78
Differing effects of exogenous or endogenous cathelicidin on macrophage toll‐like receptor signaling
da Silva, F. P., Gallo, R. L., & Nizet, V. (2009) · Immunology and Cell Biology · doi:10.1038/icb.2009.19 · Cited by 61
Expression of antimicrobial peptides in different subtypes of cutaneous lupus erythematosus
Kreuter, A., Jaouhar, M., Skrygan, M., Tigges, C., Stücker, M., Altmeyer, P. J., Gläser, R., & Gambichler, T. (2011) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2010.12.012 · Cited by 58
Nijnik, A., Pistolic, J., Filewod, N. C. J., & Hancock, R. E. W. (2012) · Journal of Innate Immunity · doi:10.1159/000335901 · Cited by 55
Säll, J., Carlsson, M., Gidlöf, O., Holm, A., Humlén, J., Öhman, J. N., Svensson, D., Nilsson, B., & Jönsson, D. (2013) · Journal of Innate Immunity · doi:10.1159/000346587 · Cited by 54
Plasmacytoid Dendritic Cells in Atherosclerosis
Döring, Y., & Zernecke, A. (2012) · Frontiers in Physiology · doi:10.3389/fphys.2012.00230 · Cited by 50
Using antimicrobial host defense peptides as anti-infective and immunomodulatory agents
Kruse, T., & Kristensen, H. (2008) · Expert Review of Anti-infective Therapy · doi:10.1586/14787210.6.6.887 · Cited by 48
Li, D., Beißwenger, C., Herr, C., Schmid, R. M., Gallo, R. L., Han, G., Zakharkina, T., & Bals, R. (2013) · Oncogene · doi:10.1038/onc.2013.248 · Cited by 43
Chotjumlong, P., Bolscher, J. G. M., Nazmi, K., Reutrakul, V., Supanchart, C., Buranaphatthana, W., & Krisanaprakornkit, S. (2012) · Journal of Innate Immunity · doi:10.1159/000342928 · Cited by 38
Alveolar Macrophage Cathelicidin Deficiency in Severe Sarcoidosis
Barna, B. P., Culver, D. A., Kanchwala, A. A., Singh, R. J., Huizar, I., Abraham, S., Malur, A., Marshall, I., Kavuru, M. S., & Thomassen, M. J. (2012) · Journal of Innate Immunity · doi:10.1159/000339149 · Cited by 23
Iannuccelli, C., Sarzi‐Puttini, P., Atzeni, F., Cazzola, M., Franco, M. D., Guzzo, M. P., Bazzichi, L., Cassisi, G., Marsico, A., Stisi, S., et al. (2011) · PubMed · Cited by 12
Cited by
Kumar, D. K. V., Choi, S. H., Washicosky, K. J., Eimer, W. A., Tucker, S., Ghofrani, J., Lefkowitz, A., McColl, G., Goldstein, L. E., Tanzi, R. E., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aaf1059 · Cited by 971
The immunology of host defence peptides: beyond antimicrobial activity
Hancock, R. E. W., Haney, E. F., & Gill, E. E. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.29 · Cited by 945
Tohme, S., Yazdani, H. O., Al-Khafaji, A. B., Chidi, A. P., Loughran, P., Mowen, K., Wang, Y., Simmons, R. L., Huang, H., & Tsung, A. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1591 · Cited by 694
Immune defence against Candida fungal infections
Netea, M. G., Joosten, L. A. B., van der Meer, J. W. M., Kullberg, B.-J., & van de Veerdonk, F. L. (2015) · Nature Reviews Immunology · doi:10.1038/nri3897 · Cited by 642
Role of Metabolic Endotoxemia in Systemic Inflammation and Potential Interventions
Mohammad, S., & Thiemermann, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.594150 · Cited by 585
Metadata
- Authors
- Kahlenberg, J. M., & Kaplan, M. J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2013-11
- Volume
- 191
- Issue
- 10
- Pages
- 4895-4901
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2096015012
- Cited by
- 428
- References
- 82
- FWCI
- 17.77
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.